this invention relates to a series of substituted aromatic ethers of the formula i wherein ring a and x and y are defined as in the specification , that exhibit activity as glycine transport inhibitors , their pharmaceutically acceptable salts , pharmaceutical compositions containing them , and their use for the enhancement of cognition and the treatment of the positive and negative symptoms of schizophrenia and other psychoses in mammals , including humans .